about
Rapamycin-conditioned, alloantigen-pulsed myeloid dendritic cells present donor MHC class I/peptide via the semi-direct pathway and inhibit survival of antigen-specific CD8(+) T cells in vitro and in vivo.Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?Effects of Foxp3 gene modified dendritic cells on mouse corneal allograft rejection.Experimental study of the mechanism of tolerance induction in dexamethasone-treated dendritic cells.Antigen-specific immunotherapy for autoimmune diseases.Immunoregulatory dendritic cells to prevent and reverse new-onset Type 1 diabetes mellitus.CD47 is required for suppression of allograft rejection by donor-specific transfusion.In vivo delivery of nucleic acid-formulated microparticles as a potential tolerogenic vaccine for type 1 diabetes.Involvement of suppressive B-lymphocytes in the mechanism of tolerogenic dendritic cell reversal of type 1 diabetes in NOD miceDendritic cell-based therapy in Type 1 diabetes mellitus.CD47 in xenograft rejection and tolerance induction.Therapeutic potential of semi-mature dendritic cells for tolerance induction.Light at the end of the tunnel?CD40 Ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides.Alloantigen specific deletion of primary human T cells by Fas ligand (CD95L)-transduced monocyte-derived killer-dendritic cells.Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity.Co-Stimulation-Impaired Bone Marrow-Derived Dendritic Cells Prevent Dextran Sodium Sulfate-Induced Colitis in Mice.
P2860
Q35083846-5071C543-FD2F-4A78-8648-68625D1F666FQ35116303-682F8915-75EC-4846-8E17-C3E8A680187DQ35643823-33BDBEAC-D141-43ED-9A10-DBE95411E0D9Q36516599-DA56C807-7FD8-485D-9267-B6148CCD91D5Q36739772-CA17D739-77BF-4B87-B31E-54D1EF650456Q36897372-5FF064F6-F584-403D-939F-162B79BD8C75Q36897526-F4FBAA34-456A-4D1C-ABBE-FE0FF36C1D94Q37088220-4A4D5909-7FCF-4CA9-B4B5-0EDEA207BC57Q37490637-BCA101B2-1E77-4608-B7A1-F676FB3FC89DQ37754644-D62380B8-E18F-493C-8DAD-AE7365D2740FQ37781118-4FE54C45-486B-4DAC-9502-F6AAA43B09C9Q39613283-5AF347B5-0485-4516-9122-91E9B7C40E0AQ43456034-141F38DC-4EB1-446C-9CDB-A1D9755A9FC2Q48371221-EB7D795F-0025-4B46-AF66-D0FB6C415094Q50526246-9A49B586-4F99-4175-B6E2-E35282ACED06Q53255338-7BA41D8D-FF59-491E-8CBF-1AAA7679053BQ55153552-BCD65ED8-1420-41AE-BDC2-49B10AF51A9E
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Dendritic cells as promoters of transplant tolerance.
@ast
Dendritic cells as promoters of transplant tolerance.
@en
type
label
Dendritic cells as promoters of transplant tolerance.
@ast
Dendritic cells as promoters of transplant tolerance.
@en
prefLabel
Dendritic cells as promoters of transplant tolerance.
@ast
Dendritic cells as promoters of transplant tolerance.
@en
P2860
P356
P1476
Dendritic cells as promoters of transplant tolerance.
@en
P2093
Angus W Thomson
Mahyar Nouri-Shirazi
P2860
P304
P356
10.1517/14712598.6.4.325
P407
P577
2006-04-01T00:00:00Z